Upajak 15 mg (Upadacitinib)
💊 Indications:
Upajak (Upadacitinib 15 mg) is primarily used in the treatment of:
-
Moderate to severe rheumatoid arthritis (RA) in patients who have had an inadequate response or intolerance to methotrexate.
-
Psoriatic arthritis (PsA)
-
Ankylosing spondylitis (AS)
-
Other autoimmune conditions as determined by a physician.
It provides an oral, non-biologic alternative to injectable biologic therapies, offering convenience and consistent dosing.
⚙️ Mechanism of Action:
Upadacitinib works by selectively inhibiting JAK1, an enzyme involved in the signaling of various cytokines and growth factors that are crucial in hematopoiesis and immune function. By inhibiting this enzyme, Upajak reduces inflammation, joint pain, and swelling in autoimmune diseases.
📋 Dosage & Administration:
-
The recommended dose is one tablet (15 mg) once daily.
-
Should be taken at the same time each day, with or without food.
-
Swallow whole; do not crush, split, or chew.
⚠️ Precautions & Warnings:
-
Contraindicated in patients with known hypersensitivity to Upadacitinib or any component of the formulation.
-
Use with caution in patients with chronic infections, liver disease, or risk of thrombosis.
-
Regular monitoring of liver function tests, CBC, and lipid profile is recommended.
-
Not recommended during pregnancy or breastfeeding without medical advice.
🔬 Quality Assurance:
Manufactured by Everest Pharmaceuticals Ltd., Upajak is produced in facilities that adhere to current Good Manufacturing Practices (cGMP). The formulation is designed for consistent drug release, high efficacy, and excellent patient tolerance.
📦 Distribution Information:
Distributed by: NP Molecule
📍 Address: Sector-14, Uttara, Dhaka-1230, Bangladesh
📞 Phone: +8801844288466
📧 Email: npmolecule23@gmail.com
🌐 Website: www.npmoleculeoncology.com
Two QR codes are provided on the box for easy access to product and prescribing details via mobile scan.
🔖 Tagline Suggestion:
“Upajak – Targeted Relief. Trusted Care.”
Related products
-
Ribokis 200 mg Tablet
Read moreRibokis 200 mg Tablet Generic Name: RibociclibBrand Name: RibokisStrength: 200 mgForm: Film-coated Oral TabletPack Size: Commonly 21 tablets per packManufacturer: Everest PharmaceuticalsDistributed by: Nasima Pharma Indications: Ribokis (Ribociclib) is indicated for the treatment of: Hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancerIn combination with: An aromatase inhibitor as initial endocrine-based therapy Fulvestrant in patients …
-
Rezdiffra (Resmetirom) Tablets – 80 mg
Read moreRezdiffra is the first FDA-approved oral therapy for noncirrhotic NASH with liver fibrosis. Available in 80 mg and 100 mg strengths, it works as a selective THR-β agonist to reduce liver fat, inflammation, and fibrosis—helping improve overall liver health without affecting heart or bone function.
-
Liposem 2 mg Tablet
Read moreLiposem 2 mg (Saroglitazar Magnesium) is an advanced oral therapy for diabetic dyslipidemia and hypertriglyceridemia. Acting as a dual PPAR α/γ agonist, it helps reduce triglycerides while improving insulin sensitivity. Manufactured by Everest, Liposem offers dual metabolic benefits in a single daily dose.
-
-
REMATIB – 15 mg (Upadacitinib INN)
Read moreUpadacitinib Hemihydrate Composition: Each Extended-Release Tablet Contains Upadacitinib 15mg as Upadacitinib Hemihydrate. Indication: Rematib is a Janus Kinase (JAK) inhibitor indicated for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to one or more TNF blockers. Adults and pediatric patients 12 years of age …
-
Rezdiffra (Resmetirom) Tablets – 100 mg
Read moreRezdiffra is the first FDA-approved oral therapy for noncirrhotic NASH with liver fibrosis. Available in 80 mg and 100 mg strengths, it works as a selective THR-β agonist to reduce liver fat, inflammation, and fibrosis—helping improve overall liver health without affecting heart or bone function.
Reviews
There are no reviews yet.